CMN1 Stock Chart & Stats
CHF6.14
--
Market closed
CHF6.14
--
Day’s Range― - ―
52-Week RangeCHF5.63 - CHF6.22
Previous CloseN/A
VolumeN/A
Average Volume (3M)34.00
Market Cap
CHF1.62B
Enterprise ValueCHF1.59K
Total Cash (Recent Filing)CHF44.70M
Total Debt (Recent Filing)CHF189.20M
Price to Earnings (P/E)44.1
Beta0.96
Next Earnings
Dec 15, 2026EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding272,126,800
10 Day Avg. Volume0
30 Day Avg. Volume34
Financial Highlights & Ratios
PEG Ratio1.11
Price to Book (P/B)4.06
Price to Sales (P/S)3.12
P/FCF Ratio-277.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF7.31Price Target Upside19.05% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)<0.01
Revenue Forecast (FY)CHF6.09M
Bulls Say, Bears Say
Bulls Say
Improving ProfitabilityImproved net, EBIT, and EBITDA margins indicate stronger operating efficiency and profitability in the core business. If maintained, this gives Chemring greater capacity to reinvest in defence programmes, absorb cost pressure, and convert revenue into sustainable earnings over the coming quarters.
Manageable LeverageModerate leverage and a substantial equity funding base provide financial resilience for a defence supplier exposed to programme timing. Healthy return on equity also suggests capital is being deployed effectively, while the balance sheet should preserve flexibility for investment and contract execution.
Multi-Year Defence ProgrammesChemring’s exposure to government customers, framework agreements, and multi-year defence programmes can support recurring demand beyond individual product deliveries. Countermeasure replenishment, training consumption, upgrades, and through-life services may reinforce customer relationships and improve revenue visibility.
Bears Say
Revenue ContractionThe revenue decline indicates that stronger margins are not currently being supported by top-line expansion. Continued contraction could limit operating leverage, reduce the scale available to fund research and programme investment, and make earnings more dependent on efficiency gains rather than business growth.
Sharp Free Cash Flow DeteriorationThe sharp deterioration in free cash flow weakens the quality and flexibility of reported earnings, even though operating cash flow was strong relative to net income. Persistent cash conversion pressure could constrain internally funded investment, debt reduction, and shareholder distributions.
Declining Earnings Per ShareA material decline in EPS signals that earnings available per share are under pressure despite improved reported margins. If the trend persists, it could indicate that profitability gains are not offsetting weaker revenue or other factors, reducing the durability of shareholder-level earnings growth.
Chemring News
CMN1 FAQ
What was Chemring’s price range in the past 12 months?
Chemring lowest stock price was CHF5.63 and its highest was CHF6.22 in the past 12 months.
What is Chemring’s market cap?
Chemring’s market cap is CHF1.62B.
When is Chemring’s upcoming earnings report date?
Chemring’s upcoming earnings report date is Dec 15, 2026 which is in 74 days.
How were Chemring’s earnings last quarter?
Chemring released its earnings results on Jun 02, 2026. The company reported CHF0.067 earnings per share for the quarter.
Is Chemring overvalued?
According to Wall Street analysts Chemring’s price is currently Undervalued.
Does Chemring pay dividends?
Chemring does not currently pay dividends.
What is Chemring’s EPS estimate?
Chemring’s EPS estimate is 0.15.
How many shares outstanding does Chemring have?
Chemring has 272,126,800 shares outstanding.
What happened to Chemring’s price movement after its last earnings report?
Chemring reported an EPS of CHF0.067 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Chemring?
Currently, no hedge funds are holding shares in CH:CMN1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chemring Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF7.31 (19.05% Upside)
CHF7.31 (19.05% Upside)
Insider Transactions
Sold Shares
Worth CHF1.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.16%
12-Months-Change
Fundamentals
Return on Equity
1.42%
Trailing 12-Months
Asset Growth
20.26%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Chemring
Chemring Group Plc engages in the manufacture of technology products and services for the aerospace, defense, and security markets. It operates through the following segments: Sensors & Information; and Countermeasures & Energetics. The Sensors & Information segments provides consulting and technology services to solve security-critical issues. The Countermeasures & Energetics segment comprises of development and manufacture of expendable countermeasures for air and sea platforms, cartridge and propellant actuated devices, pyrotechnic devices for satellite launch and deployment, missile components, propellants, separation sub-systems, actuators, and energetic materials. The company was founded on November 30, 1905 and is headquartered in Romsey, the United Kingdom.
CMN1 Stock 12 Month Forecast
Average Price Target
CHF7.31
▲(19.05% Upside)